Some 25 years ago, a young Parkinson's disease investigator, Robert Hauser, MD, stepped to the podium at an American Academy ...

Groundbreaking research by the University of Sydney has identified a new brain protein involved in the development of ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

About half of those diagnosed with Parkinson's develop dementia within 10 years, profoundly affecting patients, families and the health care system ...

Understand Parkinson's disease, its symptoms, and the crucial role of clinical trials in treatment and research, especially for Black Americans.

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Scientists find volatile compounds in ear wax may help detect Parkinson's disease earlier than traditional methods, offering ...